United Kingdom 
DERMICUS Teledermatology
The specialised teledermatology platform - today, and for the future
Why teledermatology?
The NHS states that in 2019-20 there were 3 million dermatology outpatient appointments in England, making it the sixth highest treatment function in terms of volume.
Why implement teledermatology with Dermicus?
Dermicus is specialised for dermatology – founded by a dermatology consultant. We only work with dermatology pathways and customers.
Skin cancer
Skin cancer is the most common cancer in the UK, and dermatology services receive more urgent referrals for suspected cancer than any other speciality.
Outpatient pressure
Before Covid-19 outpatient services were already under pressure, and so now the NHS is stating that clinicians should consider avoiding physical outpatient appointments.
Timely care
The main long-term benefit of teledermatology triage is to ensure patients receive timely care in the most appropriate setting and at greater convenience. This increases capacity in secondary care for patients who need face-to-face referrals.
Specialised for dermatology
Future-proofed for dermatology
Dermicus is NHS compliant and flexible for how you need to implement teledermatology – now and for the future.
Whether your organisation needs to address the challenge faced in general dermatology or specific pathways such as skin cancer, Dermicus will meet your needs.
Examples of Dermicus implementation include:
- Triage suspected cancer including 2WW
- A&G requests and referrals
- Routine dermatology referrals
- Patient submitted images
- AI studies and research
NHS compliance
Passed – Dermicus has passed the NHSX DTAC (Digital Technology Assessment Criteria)
Certified – ISO/IEC 27001
Clinical safety DCB 0129
Independent penetration tested
Integrations into primary and secondary care
Information Governance (IG) and GDPR.
Collaboration
Secure collaboration for multi-disciplinary teams across primary and secondary care.
Enabling safe triage of suspected cancer referrals local skin cancer multidisciplinary team (LSMDT) or specialist skin cancer multidisciplinary team (SSMDT).
Users can be added from other clinicians e.g. pathology supporting the pathway.
Easy NHS procurement
To support easier procurement, Gnosco (Dermicus) has been awarded a place on the GP IT Futures Framework Lot 1 – professional to professional consultation and is also listed on the G-Cloud 12 framework.
Beyond the initial implementation
The Dermicus Teledermatology platform is configurable to support AI studies in dermatology. AI will be a part of the future of dermatology care. Gnosco is already supporting researchers with their work to understand and evidence the safe use of AI for dermatology patients.
I have still been able to offer a consultant opinion, with the confidence that this is accurate and useful. In addition, because the images are able to be stored, should there be any question over the diagnosis in the future, the images would be available for audit.
Dr Richard Ashton
Self-isolating consultant due to Covid-19
The Dermicus App is an excellent tool for primary care clinicians, providing a reliable interface with a skin specialist. It saves time and costs and improves the efficiency of assessments.
Dr Kevin Gallagher
Salaried GP
[Because I am] quite moley - knowing this can be easily done is very reassuring.
NHS patient
Isle of Wight
